We are live on !
Find out more
Bard Associates Portfolio holdings
AUM
$431M
Turnover
22.88%
1-Year Est. Return
30.93%
This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+30.93%
3 Year Est. Return
+246.87%
5 Year Est. Return
+265.82%
10 Year Est. Return
+1,236.5%
AUM
$431M
AUM Growth
-$19.6M
(-4.4%)
Cap. Flow
+$15.2M
Cap. Flow % of AUM
Cap. Flow %
3.52%
Top 10 Holdings %
Top 10 Hldgs %
37.05%
Holding
354
New
61
Increased
119
Reduced
69
Closed
20
Avg Time Held
Equity + Options
2.6
years
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1.8
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$2.04M |
| 2 |
Janus Henderson Securitized Income ETF
JSI
|
+$1.38M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$1.09M |
| 4 |
iShares Residential and Multisector Real Estate ETF
REZ
|
+$900K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$844K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
M-tron Industries
MPTI
|
+$1.28M |
| 2 |
NeuroOne Medical Technologies
NMTC
|
+$929K |
| 3 |
The Ensign Group
ENSG
|
+$866K |
| 4 |
Venu Holding Corp
VENU
|
+$403K |
| 5 |
Clearfield
CLFD
|
+$293K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.76% |
| 2 | Technology | 17.25% |
| 3 | Materials | 10.42% |
| 4 | Industrials | 6.11% |
| 5 | Consumer Staples | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
351
Venu Holding Corp
VENU
$63.9M
| – | – |
-177,661
| Closed | -$403K | – |
|
352
Callan JMB Inc
CJMB
$2.86M
| – | – |
-229,250
| Closed | -$184K | – |
|
353
Elevra Lithium Ltd
ELVR
$480M
| – | – |
-175
| Closed | -$11.9K | – |
|
|
MBGL
354
Mobility Global Inc
MBGL
$7.45B
| – | – |
-12
| Closed | -$265 | – |
|
Similar funds
CWM
MCM
Bard Associates's Q3 2026 Portfolio in Review
As of Q3 2026, Bard Associates held 354 positions worth $431M, down 4.4% from $451M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Bard Associates deployed $15.2M of net new capital in Q3 2026, opening 61 new positions and adding to 119 existing holdings. Its largest new stake was iShares Russell Mid-Cap Value ETF: 4,722 shares worth $759K.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 36% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was M-tron Industries, an estimated $1.28M trimmed.
- Bard Associates's largest Q3 2026 buy was iShares Russell Mid-Cap Value ETF: 4,722 shares worth $759K.
- Bard Associates added most to Schwab Short-Term US Treasury ETF in Q3 2026, an estimated $2.04M increase.
- Bard Associates's biggest Q3 2026 reduction was M-tron Industries, cutting an estimated $1.28M.
- Bard Associates fully exited NeuroOne Medical Technologies in Q3 2026, selling an estimated $929K.
- Bard Associates's ten largest holdings make up 37% of its $431M portfolio in Q3 2026.
- Bard Associates opened 61 new positions and closed 20 in Q3 2026.
- Bard Associates's portfolio value fell 4.4% quarter-over-quarter to $431M.
Based on Bard Associates's 13F filing for Q3 2026, filed 13 Nov 2026.